Anticoagulants Market Size (2024 - 2029)

Anticoagulants Market Analysis

The Anticoagulants Market size is estimated at USD 24.20 billion in 2024, and is expected to reach USD 34.40 billion by 2029, growing at a CAGR of 7.29% during the forecast period (2024-2029).

Factors such as an increase in the incidence of chronic diseases with a rise in the adoption of novel anticoagulant medicines are likely to drive market growth. For example, according to the May 2024 update by the Centers for Disease Control and Prevention, about 1 in 20 adults aged 20 and older have coronary artery disease (CAD) in the United States. Further, as per the same source, every 40 seconds, someone suffers from a heart attack, and nearly 805,000 people in the United States have a heart attack every year. Thus, the growing burden of coronary artery disease is expected to increase the demand for anticoagulants, thereby contributing to the growth of the market.

Moreover, the regulatory approval of anticoagulant products is also propelling the growth of the market. For example, in March 2023, Techdow USA Inc. received US Food and Drug Administration (FDA) approval for enoxaparin sodium (preservative-free) in prefilled syringes for the US market. The launch of Enoxaparin is expected to complement Techdow USA’s existing heparin sodium injection business, which was launched in 2022. Hence, the active presence of key market players and strategic product launches are expected to augment the market growth during the forecast period. Additionally, the demand for anticoagulants in chronic disease therapy is expected to drive market expansion during the forecast period. For instance, as per the BHF report published in 2023, 1,372 anticoagulant and protamine medicines were prescribed during 2021-2022 in Wales for the prevention and treatment of heart and circulatory diseases.

Therefore, the market is expected to witness notable growth during the forecast period due to the increase in chronic disease complications and advancements in anticoagulant therapies coupled with strategic activities by the key players. However, stringent regulation and side effects associated with the treatment will restrain the market growth during the forecast period.

Anticoagulants Industry Segmentation

As per the scope of the report, anticoagulants are medicines used to treat and prevent blood clots that may occur in blood vessels.

The anticoagulants market is segmented by drug class, application, and geography. By drug class, the market is segmented into novel oral anticoagulants (NOACs), heparin, low molecular weight heparin (LMWH), and vitamin K antagonists. By application, the market is segmented into atrial fibrillation/myocardial infarction, deep vein thrombosis (DVT), pulmonary embolism, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments.